Research Studies

CODA participates in various types of research including surveys, observational studies and clinical trials that may involve medications – all have different eligibility criteria.

All participants go through the informed consent process which provides them with clear explanations of the rights and risks prior to joining a research study.

To learn more about current studies:
Email: research@codainc.org

Some of our studies provide medications at no cost

You will be compensated for participating

Your personal information is confidential

We are currently recruiting for the following studies:

Extended-Release Naltrexone Injection/Bupropion XL Tablets in the Treatment of Methamphetamine Use Disorder (Bup-Viv)

Do you want to stop or reduce your methamphetamine use, and interested in participating in a research study? If so, please reach out to research@codainc.org, call or text us at text 971-381-0357, or use the “Contact Us” button to the right. You will be compensated for your time and effort!

CODA, Inc. is working with the National Institute on Drug Abuse (NIDA) and the Veterans Affairs (VA) on a research study. The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL compared to a placebo in reducing methamphetamine use in individuals with moderate or severe methamphetamine use disorder. If found eligible, you would receive a monthly injection of the active medication or a placebo at no cost to you.

Interested in participating?

For more information:

971-381-0357

research@codainc.org

HEALthy Brain and Child Development (HBCD)

Are you currently pregnant and interested in participating in a research study? If so please reach out to hbcdstudy@ohsu.edu or call us at 503-418-9334. You will be compensated for your participation!

CODA, Inc. is working with Oregon Health and Science University (OHSU) on “The HEALthy Brain and Child Development (HBCD) Study”. We are recruiting a large cohort of pregnant women affected by the opioid crisis and will be following them and their children through early childhood. This study does not provide any medication to you or your infant.